Delighted to have been selected by EIT Health as a semi-finalist. Wonderful to be recognised for our groundbreaking work in advancing breast cancer biomarker analytics.


Digistain Presents Key Research Findings at the San Antonio Breast Cancer Symposium 2024
Last week, we were proud to present two abstracts at the San Antonio Breast Cancer Symposium 2024. The first abstract showcased head-to-head data from Charing